Antibody Identified in Patients With Autoimmune Pancreatitis
Posted by Admin | Posted in Medical Lawyers | Posted on 26-11-2009
Researchers have identified an antibody that is present in the serum of most patients who have autoimmune pancreatitis and may eventually help in the differential diagnosis of the disorder, according to a report in the Nov. 26 issue of the New England Journal of Medicine.
Chronic Musculoskeletal Pain Raises Risk of Falling in Elderly
Posted by Admin | Posted in Medical Lawyers | Posted on 25-11-2009
Chronic musculoskeletal pain raises elderly peoples risk of falling, independent of their underlying pathologies or the medications they may be taking for the pain, according to a study of more than 700 elders living independently.
Unpublished Research Signaled Rofecoxib CV Risk as Early as 2001, Study Alleges
Posted by Admin | Posted in Medical Lawyers | Posted on 24-11-2009
Tamiflu-Resistant H1N1 Influenza Found in Wales
Posted by Admin | Posted in Medical Lawyers | Posted on 22-11-2009
The British Health Protection Agency has confirmed five patients with oseltamivir-resistant pandemic influenza A(H1N1) virus on a hospital ward in Wales.
ACOG Recommends Changes in Cervical Screening
Posted by Admin | Posted in Medical Lawyers | Posted on 20-11-2009
The American College of Obstetricians and Gynecologists announced Nov. 20 that it is now recommending delaying the start of cervical cancer screening until age 21 and then screening most patients every other year instead of annually.
FDA Panel Recommends Approval of Pneumococcal Disease Vaccine
Posted by Admin | Posted in Medical Lawyers | Posted on 19-11-2009
BETHESDA, Md. (EGMN) A Food and Drug Administration advisory panel voted on Nov. 18 in favor of recommending Pfizers 13-valent pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease.
U.S. Senate Holds Hearing on H1N1 Vaccine Shortages
Posted by Admin | Posted in Medical Lawyers | Posted on 18-11-2009
The U.S. Senates Homeland Security and Governmental Affairs Committee held a hearing Nov. 17 to determine why vaccine for pandemic influenza A(H1N1) virus is taking so long to reach the 159 million Americans in the designated high-risk groups.
Guidelines for Stage IV NSCLC Edge Toward Individualized Therapy Choices
Posted by Admin | Posted in Medical Lawyers | Posted on 17-11-2009
The first substantial revisions in the American Society of Clinical Oncologys clinical guideline for the treatment of stage IV nonsmall cell lung cancer in 6 years acknowledges the burgeoning role for individualization of therapy according to patient characteristics, including epidermal growth factor receptor mutation status and performance status rather than age.
FDA Approves Oral Menorrhagia Therapy
Posted by Admin | Posted in Medical Lawyers | Posted on 14-11-2009
The Food and Drug Administration on Nov. 13 approved Lysteda, a proprietary form of tranexamic acid, for the treatment of menorrhagia.
